PHARMACY

Lupin receives FDA nod for two generics
Lupin received the Food and Drug Administration’s approval to launch generic PreCision Locoid lotion and Temovate cream.
Generics makers look to keep offerings competitive, affordable
One of the greatest challenges the generics industry has been facing is a product supply shortage that has been caused by a number of generics companies exiting the industry.

FDA acts to mitigate EpiPen shortages

In an effort to end recent shortages of EpiPen auto-injector, the FDA is extending the expiration date of specific lots of products marketed by Mylan.
Amneal inks licensing deal for levothyroxine

Amneal will market Jerome Steven' generic levothyroxine sodium tablets for hypothyroidism and pituitary TSH suppression.
FDA OKs third Lenvima indication

Eisai and Merck's third approved indication for Lenvima is for the first-line treatment of patients with unresectable hepatocellular carcinoma.
Hy-Vee pharmacies are set to give flu vaccines in store and corporate locations

Hy-Vee is stocked with flu vaccines in more than 250 of its pharmacy locations, and it is offering corporate flu clinics.
Walgreens, VA partner to improve care coordination

Through the partnership, Dept. of Veterans Affairs providers will be able to see the entire medication and immunization history of the VA-enrolled patient, if they receive prescriptions and immunizations at Walgreens.
Regeneron gets FDA nod for updated Eylea label

Regeneron Pharmaceuticals has received the green light from the Food and Drug Administration for a supplemental Biologics License Application for Eylea (aflibercept) injection in patients with wet age-related macular degeneration, or wet AMD).
Novadoz Pharmaceuticals to launch first 3 U.S. generics

Novadoz's generics of Crestor, Avelox and Xeloda were approved by the Food and Drug Administration in the fall of 2017.
Sun Pharma gets FDA nod for Cequa's dry eye treatment

Sun Pharma’s Cequa (cyclosporine ophthalmic solution) 0.09% for topical ophthalmic use combines cyclosporine A with nanomicellar technology, the company said.